title: AIDS drugs & the pharmaceutical industry: a need for reform.
abstract: The pharmaceutical industry has long enjoyed substantial profits despite increased requirements for drug approval and various attempts to regulate the industry. Drug companies have avoided effective regulation by blaming high prices on the costs of research and development. The search for drugs effective in combatting HIV and AIDS related illnesses has provided a stark background on which to view the actions and justifications of drug companies. Despite increased cooperation between government and the drug industry and expedited approval of several useful drugs, these drugs are still prohibitively expensive. This Article explores the history and economics of the drug industry and proposes a system of national price regulation for all drugs.
authors.affiliation: Temple University School of Law.
authors.forename: M T
authors.initials: MT
authors.lastname: Griffin
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D035843:Biomedical Research; D003363:Cost Control; D003365:Costs and Cost Analysis; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry / Q000191:economics*; D011307:Drug Prescriptions / Q000191:economics*; D035082:Federal Government; D033161:Government Regulation; D006801:Humans; D038622:Internationality; D007880:Legislation, Drug; D036302:Therapeutic Human Experimentation; D014481:United States